This instalment provides a brief overview of some multidimensional approaches targeted at intact protein analysis for life
science applications, particularly for biopharmaceutical analysis.
Since the 1944 publication of a paper by Consden, Gordona and Martin (1) describing multidimensional separations, the prospect
of using this technique to address complex analytical challenges has sustained the interest of the analytical chemistry community.
Analysts often use multidimensional techniques when they require higher separation capacity than single-dimension analyses
can afford. By using dimensions of various selectivity for complex analytes such as food, polymers and hydrocarbons, maximum
resolution can be achieved among components that are generally difficult to separate using a single-dimension technique.
The multidimensional approach for separations has been — and continues to be — highly utilized. Not surprisingly, its use
as an analytical technique has been expanded. It now includes various applications that do not necessarily result in greater
resolution. In those applications, the technique serves as the means for conducting separate analyses of the same analyte
without the need for multiple instruments. It can also reduce steps for sample preparation and provide a convenient way to
perform automated assays.
In the past few years, an emerging area of focus in the pharmaceutical industry is the biopharmaceuticals. The compounds in
this class are very complex and require a high degree of characterization. Indeed, the level of characterization necessary
is increasing, largely because of improved analytical technologies and regulatory requirements. What's also at play is the
emergence of biosimilar approval pathways, in which protecting intellectual property for innovators or proving similarity
for biosimilar producers is increasingly important (2).
Developing and manufacturing biopharmaceuticals requires amassing a variety of chromatographic and mass spectral data. The
different chromatographic modes probe particular characteristics of the analyte. Some of these characteristics include size,
charge and mass profile. As such, they are related to, or are themselves, critical quality attributes.
For some biopharmaceutical applications, a multidimensional separation can reduce a practitioner's analytical burden, yielding
greater assay reproducibility by dispensing with hands-on sample preparation. Note, however, that although adding chromatographic
dimensions can prove useful, to do so without realizing additional benefit, such as increased resolution, sensitivity,or automation,
introduces unnecessary complexity.
This column instalment provides a brief overview of some multidimensional approaches targeted at intact protein analysis for
life science applications, particularly for biopharmaceutical analysis. For the applications described here, adding a liquid
chromatography (LC) dimension automates sample preparation and provides a convenient means of analysing an analyte by different
methods that require different chromatographic eluents. As such, these applications are meant for targeted analyses where
sample complexity does not demand adding a dimension. Rather, the criterion for needing a multidimensional separation is the
primary chromatographic method's incompatibility with the desired detection method. For example, because of high mobile-phase
salt concentrations, ion-exchange chromatography (IEC) is incompatible with mass spectrometry (MS) detection directly. Capturing
a peak of interest to a second-dimension reversed-phase column, however, allows for desalting the analyte and collecting MS